Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Pavla Pecherková's publication output changed over time?
ScholarIQpublication output · 2016–2023
Output grew0% over the shown period — from 1 works in 2016 to 1 in 2023.
1
2
2
3
1
1
1
2016201720182020202120222023
What are the most-cited papers on Pavla Pecherková?
ScholarIQmost cited works
Understanding the potential of MaaS – An European survey on attitudes
Michal Matowicki, Marco Amorim, Mira Kern, Pavla Pecherková, Nicolaj Motzer, Ondrej Přibyl
S2764874763. 202279 Citations
BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia
Klára Šrůtová, Nikola Čuřík, Pavel Burda, Filipp Savvulidi, Giovannino Silvestri, Rossana Trotta, Hana Klamová, Pavla Pecherková, Žofie Sovová, Jitka Koblihova, Tomáš Stopka, Danilo Perrotti, Kateřina Machová Poláková
S2752781272. 201846 CitationsOPEN ACCESS
Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome
Andrea Hruštincová, Zdeněk Krejčík, Dávid Kundrát, Katarína Szikszai, Monika Beličková, Pavla Pecherková, Jǐŕı Kléma, Jitka Veselá, Monika Hruba, Jaroslav Čermák, Tereza Hrdinova, Matyáš Krijt, J Válka, Anna Jonášová, Michaela Dostálová Merkerová
S2736626452. 202041 CitationsOPEN ACCESS
Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission
Kateřina Machová Poláková, Hana Žižková, Jan Zuna, Eliska Motlova, Lenka Hovorková, Andrea Gottschalk, Ingmar Glauche, Jitka Koblihova, Pavla Pecherková, Hana Klamová, Marketa Stastna Markova, Dana Srbová, Adela Benesova, Václava Polívková, Tomáš Jurček, Daniela Žáčková, Jiřı́ Mayer, Thomas Ernst, François Xavier Mahon, Susanne Saußele, Ingo Roeder, Nicholas C.P. Cross, Andreas Hochhaus
S149476849. 202030 CitationsOPEN ACCESS
Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment
Monika Jaruskova, Nikola Čuřík, Rajna Hercog, Václava Polívková, Eliska Motlova, Vladimı́r Beneš, Hana Klamová, Pavla Pecherková, Petra Bělohlávková, Filip Vrbacký, Kateřina Machová Poláková
Journal of Experimental & Clinical Cancer Research. 201727 CitationsOPEN ACCESS
Related on ScholarIQ
Institute of Haematology and Blood Transfusion
Institution
Understanding the potential of MaaS – An European survey on attitudes
Paper
BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia
Paper
Circulating Small Noncoding RNAs Have Specific Expression Patterns in Plasma and Extracellular Vesicles in Myelodysplastic Syndromes and Are Predictive of Patient Outcome
Paper
Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission
Paper
Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment
Paper